Treating colorectal cancer cells with aspirin upregulated the expression of CD80, enhancing the cells’ ability to actively present tumor antigens to T cells. Regular long-term aspirin use may prevent the progression of colorectal cancer by boosting immunosurveillance against the disease, data suggest.